SCHEMBL21928601

SCHEMBL21928601

Cc1ccc(-c2ccc3c4ccc(-c5ccc(C)cc5)cc4n(-c4cc(-c5ccc(C#N)cc5)c(-n5c6cc(-c7ccc(C)cc7)ccc6c6ccc(-c7ccc(C)cc7)cc65)cn4)c3c2)cc1

nearest known ligand 0.39

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MAPKAPK2 P49137 1/20 0.39
CHEK1 O14757 1/20 0.39
CYP11B2 P19099 3/20 0.38
GRM2 Q14416 1/20 0.37
KDM1A O60341 10/20 0.37
ALDH1A1 P00352 2/20 0.36
KDM4E B2RXH2 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
CYP2A6 P11509 1/20 0.36
PIK3CD O00329 1/20 0.36
PIK3CA P42336 1/20 0.36
MAOB P27338 1/20 0.36
AKT1 P31749 1/20 0.36
CYP11B1 P15538 1/20 0.35
KCNH2 Q12809 2/20 0.35
RCOR1 Q9UKL0 1/20 0.35
EGLN2 Q96KS0 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21928605 0.95 PTGER4 (0.39) MAPKAPK2CHEK1CYP11B2GRM2KDM1A
SCHEMBL21929230 0.94 CHEK1 (0.37) CHEK1CYP11B2ALDH1A1KDM4EL3MBTL1
SCHEMBL23098053 0.93 GRM2 (0.41) MAPKAPK2CYP11B2GRM2KDM1AALDH1A1
SCHEMBL21929041 0.92 CYP11B2 (0.37) MAPKAPK2CHEK1CYP11B2GRM2KDM1A
SCHEMBL21931712 0.91 MAPKAPK2 (0.42) MAPKAPK2CHEK1CYP11B2GRM2KDM1A
SCHEMBL21929039 0.90 CYP11B2 (0.40) CHEK1CYP11B2GRM2KDM1AALDH1A1
SCHEMBL21931728 0.90 GABRA1 (0.40) CHEK1CYP11B2KDM1AALDH1A1MAOB
SCHEMBL21931684 0.89 KIT (0.37) ALDH1A1KDM4EPIK3CA
SCHEMBL21928431 0.89 GRM2 (0.37) CHEK1CYP11B2GRM2KDM1AALDH1A1
SCHEMBL21929229 0.89 PTGER4 (0.40) CHEK1CYP11B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220388960-A1 ORGANIC MOLECULES FOR USE IN LIGHT-EMITTING DEVICES CYNORA GMBH (DE) 2022-12-08 US disclosed
US-20200136054-A1 ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2020-04-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200136054-A1 ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES OR10J3, OGFR, OR51E2 MAPKAPK2 3575/4885CHEK1 3808/4885CYP11B2 902/4885
US-20220388960-A1 ORGANIC MOLECULES FOR USE IN LIGHT-EMITTING DEVICES ALDH1A2, AOX1, CYBA MAPKAPK2 3250/4885CHEK1 1237/4885CYP11B2 163/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.